PCM
RGNX icon

Polymer Capital Management’s Regenxbio RGNX Stock Holding History

Polymer Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,752
Closed -$199K – 920
2026
Q1 		$199K Buy
+23,752
New +$250K 0.02% 744
2025
Q3 		– Sell
-23,411
Closed -$192K – 919
2025
Q2 		$192K Buy
+23,411
New +$196K 0.02% 547

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Polymer Capital Management's RGNX Position: Q2 2026 in Review

Polymer Capital Management sold out of Regenxbio (RGNX) in Q2 2026, closing a stake of 23,752 shares — an estimated $199K sold.

Polymer Capital Management first reported a position in RGNX in Q2 2025 and held it in 2 quarters. The position peaked at $199K in Q1 2026. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Polymer Capital Management reported no remaining Regenxbio position as of Q2 2026 after selling out during the quarter.
  • Polymer Capital Management sold 23,752 Regenxbio shares in Q2 2026, an estimated $199K.
  • Polymer Capital Management first reported a position in Regenxbio in Q2 2025 and held it in 2 quarters.
  • Polymer Capital Management's Regenxbio position peaked at $199K in Q1 2026.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Polymer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.